Medical Marijuana Expected to Be Legal in All 50 U.S. States by 2024

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is one cannabis stock that’s yet to unveil its plans for the U.S., and its potential in that market could be massive.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

The U.S. cannabis market is growing rapidly, and it may not be long before we see every state have some form of marijuana legalized.

A recent report by research companies Arcview Market Research and BDS Analytics suggests that by 2024, we could see the global cannabis sales in regulated markets to reach US$40 billion, more than double the US$14.9 billion that the companies project will be achieved this year, which is a 36% increase over the prior year.

A big part of that assumption, however, is the expectation that legalization in the U.S. will continue to progress significantly in the coming years.

The companies have high expectations for the future, which they say are backed by others following cannabis legalization, “Legalization advocates endorsed our view that all fifty U.S. states can be expected to be medically legal by 2024, and that twenty will have adult-use sales.”

Are these numbers too conservative?

With more than 30 states having legalized medical marijuana thus far, it may not be that big of a leap to assume that the remaining states will legalize it in five years. It may even be a conservative assumption given how quickly we’ve seen states moving on cannabis legislation.

Reaching 20 states in the adult-use market also isn’t much growth in five years given that we’re already at 11 and we know it’s on the radar for New York and New Jersey.

The good news is that we could see a lot more progress on the legalization front than these companies are expecting, which would likely result in these estimates for the market becoming even bigger.

Growing U.S. market could be a source of significant growth for Canadian producers

One company that has its sights set on the U.S. cannabis market is Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB), which has been fairly quiet on its ambitions south of the border. However, the company has said that it will reveal its plans for the market at some point this year.

Aurora has been adding to its supply and could be poised to make a big jump into the U.S., especially now that the company has some key personnel that can help it grow via acquisition and advance its long-term strategy.

Aurora has been too quiet for too long, especially when you consider how aggressive it has been in the past. I wouldn’t be surprised if the company comes out with a big announcement at some point this year as the stakes are too high for Aurora to be sitting in the sidelines while its competitors get a leg up.

Although it wouldn’t be able to jump into the marijuana market, it would be able to take advantage of hemp being legal in the U.S. and using that as a way to penetrate the market and developing a strong customer base south of the border.

Given the success we’ve seen a company like Charlotte’s Web enjoy by focusing solely on hemp, it’s easy to see the growth potential for a company like Aurora as well.

The market in the U.S. is only getting bigger with each piece of cannabis legislation that passes, which is why it may only be a matter of time before we see Aurora make a significant move to take advantage of those opportunities.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »